The tracer
What is rubidium-82?
Rubidium-82 (Rb-82) is a positron-emitting radioactive tracer used for PET imaging of blood flow to the heart muscle. Chemically it behaves like potassium: living heart cells pump it in via the sodium–potassium (Na⁺/K⁺) ATPase, in proportion to the blood flow reaching them. It is the most widely used PET tracer for myocardial perfusion imaging worldwide. 1
What does it actually measure?
Two things are reflected in the Rb-82 PET signal. Because Rb-82 delivery to the myocardium is closely related to blood flow, it can be used to assess myocardial perfusion, both relatively and, with dynamic imaging, quantitatively as absolute myocardial blood flow. Rb-82 uptake also depends on functioning myocardial cells and active ion transport, so areas of non-viable or infarcted myocardium generally show reduced tracer uptake.
Why a 75-second half-life isn't that impractically short?
It is short (~75 seconds), and that is mostly an advantage. The rapid decay means rest and stress imaging can be performed minutes apart in one session, keeps radiation dose low, and clears residual activity quickly. The trade-off is that timing and delivery must be precise and automated, there is no margin for a slow manual injection or a mistimed acquisition.
How is Rb-82 different from F-18 or N-13 perfusion tracers?
The key differences are production and resolution. Rb-82 is generator-produced (no cyclotron); N-13 ammonia and F-18 flurpiridaz are cyclotron-dependent. In return, Rb-82 has a longer positron range, a higher-energy positron travels further before annihilating, which gives it a modestly lower intrinsic spatial resolution than those cyclotron tracers. For quantifying myocardial blood flow, that trade has proven highly favourable, which is why Rb-82 dominates clinical practice.
The generator
Where does Rb-82 come from if there's no cyclotron?
From a generator. The cyclotron work is done once, elsewhere, to make the long-lived parent isotope strontium-82 (Sr-82), which has a ~25-day half-life. Sr-82 is bound to a column inside a shielded generator; as it decays it continuously produces Rb-82, which is washed off ("eluted") on demand at the scanner. It is the same long-parent/short-daughter principle as the familiar technetium-99m generator. 2
How long does a generator last?
Its in-service life is measured in weeks. Regulatory expiration limits cap use at 42 days post-calibration, 17 litres of cumulative eluate, or defined strontium-breakthrough thresholds, whichever comes first. 3 Separately, the amount of Rb-82 it can deliver per dose declines as it ages, so heavier patients (who need larger weight-based doses) are best scheduled earlier in the generator's life. 3
What is "strontium breakthrough" and why does everyone mention it?
Strontium is the long-lived parent that is supposed to stay on the column. If it leaks into the eluate and is injected, the patient receives a bone-seeking isotope instead of a tracer that vanishes in minutes — a materially different radiation exposure. Two safeguards prevent this: using only additive-free 0.9% saline to elute (calcium-containing solutions force strontium off the column), and daily eluate testing against strict limits before the first patient. 3 This is the central safety discipline of an Rb-82 service.
Does running a generator require daily recalibration and a radiopharmacy?
No on-site cyclotron and no kit chemistry are needed. Modern infusion systems automate quality control (which can be scheduled overnight) and do not require daily calibration. Calibration is performed at installation of a new generator, after an accessory-pack change, and every 14 days. Daily eluate testing, however, remains mandatory. 3
Using it in practice
What does a full study involve?
A rest acquisition and a pharmacologic-stress acquisition, separated by a minimum 10-minute gap to let the rest dose decay. The whole rest–stress study is typically completed within about 30 minutes. 4
Why pharmacologic stress and not a treadmill?
The 75-second half-life makes exercise impractical as it is not possible to have a patient at peak treadmill exertion while a tracer that decays in seconds is infused at the scanner and imaged. Rb-82 perfusion therefore uses pharmacologic stress agents (such as vasodilators), which carry their own safety requirements. Safety requirements include testing must be carried out where cardiac resuscitation equipment and trained staff are available. 3
Can it measure absolute blood flow, or just relative perfusion?
Both. Acquired dynamically, Rb-82 PET quantifies absolute myocardial blood flow (MBF) and myocardial flow reserve (MFR), capabilities that detect balanced multivessel ischaemia and microvascular dysfunction that relative imaging can miss.
What dose does the patient receive?
The recommended administered activity is 10–30 MBq/kg per component (maximum 2,220 MBq). 3 The effective dose for a full rest–stress study is low, on the order of ~3–6 mSv depending on administered activity and acquisition mode, comfortably below the ASNC ≤9 mSv target for cardiac radionuclide imaging.
What a programme needs
What infrastructure is required to start?
A PET (or PET/CT) scanner, the Rb-82 generator, the dedicated infusion system, a reliable supply of additive-free 0.9% saline, a pharmacologic-stress setup with resuscitation cover, and trained staff. No cyclotron and no radiochemistry facility are needed.
Is special staff training needed?
Yes, for safe generator operation, daily QC, dose calibration, and quantitative acquisition. Manufacturers typically provide structured "cold" (pre-delivery) and "hot" (first-patient) training and ongoing certification. The exacting QC regimen is best treated as a trained, standardised programme rather than improvised per case.
What is the rate-limiting factor in expanding access?
Increasingly, it is supply, not technology. The generator depends on a small number of Sr-82 production facilities worldwide. Reliable delivery and access planning, a particular consideration in Southeast Asia, will determine how far a service can scale.
For patients
Is the scan safe?
Cardiac PET with rubidium is a well-established, low-radiation test that has been used for decades to assess blood flow to the heart. The radioactive tracer decays within minutes.
Will I feel the tracer?
No. The tracer itself is given through an IV and is not felt. During the stress part of the scan, a medication is used to mimic the effect of exercise on the heart; some people briefly feel flushing, breathlessness, or a headache, which passes quickly. Tell your care team about any symptoms.
How should I prepare?
Follow your centre's instructions. Typically this means not eating for several hours beforehand, avoiding caffeine for 12–24 hours (it interferes with the stress medication), staying well hydrated, and bringing a list of your medications (in case any would need to be temporarily paused). Tell your care team if you might be pregnant or are breastfeeding.
References
Bracco Diagnostics Inc. (2026). CardioGen-82 (rubidium Rb 82 generator) [Prescribing information]. U.S. Food and Drug Administration. [Clinical pharmacology — mechanism of action; nuclear physical characteristics.]
Bracco Imaging S.p.A. (2022). CardioGen-82 (rubidium-82 generator, ⁸²Rb): Summary of product characteristics. [Dosage and administration; warnings and precautions; eluate testing protocol; expiration limits; radiation dosimetry.]
Mimouni, M., Bulsei, J., Darlington, M., Estellat, C., Rouzet, F., Hyafil, F., & Durand-Zaleski, I. (2023). Cost-effectiveness of 82-rubidium PET myocardial perfusion imaging for the diagnosis of myocardial ischemia depending on the prevalence of coronary artery disease. EJNMMI Research, 13(1), 9. https://doi.org/10.1186/s13550-023-00954-x
QT Instruments (under Biomedia Holdings) supports nuclear cardiology programmes across Southeast Asia in establishing and optimising quantitative perfusion capabilities, including Rb-82 PET infrastructure, generator supply, training, and clinical and operational guidance.